Summary by Futu AI
SINO BIOPHARM announces that it will hold a Board of Directors meeting on Monday, August 18, 2025. The main agenda items include the review and approval of the unaudited interim results for the six-month period ending June 30, 2025, and the consideration of the declaration of an interim dividend.The company's Board of Directors currently consists of six executive directors and five independent non-executive directors. The executive directors are Ms. Xie Qiran, Mr. Xie Bing, Ms. Zheng Xiangling, Mr. Xie Chengrun, Mr. Xie Xin, and Mr. Tian Zhoushan; the independent non-executive directors are Mr. Lu Zhengfei, Mr. Li Daikui, Ms. Lu Hong, Mr. Zhang Lufu, and Dr. Li Guodong.